Results 1 to 10 of about 586,644 (327)

Willingness to pay for one quality-adjusted life year in Iran [PDF]

open access: yesCost Effectiveness and Resource Allocation, 2019
Background Recent years have witnessed a strong tendency to apply economic evidence as a guide for making health resource allocation decisions, especially those related to reimbursement policies.
Najmeh Moradi   +5 more
doaj   +7 more sources

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? [PDF]

open access: goldClinicoEconomics and Outcomes Research, 2013
Montarat Thavorncharoensap,1,2 Yot Teerawattananon,2 Sirin Natanant,2 Wantanee Kulpeng,2 Jomkwan Yothasamut,2 Pitsaphun Werayingyong21Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand; 2Health Intervention and Technology ...
Thavorncharoensap M   +5 more
doaj   +5 more sources

Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China. [PDF]

open access: bronzeAppl Health Econ Health Policy, 2022
The aim of this study was to estimate the population’s willingness to pay (WTP) for an additional quality-adjusted life-year (QALY) in China. The WTP for an additional QALY (WTP/Q) was estimated using a contingent valuation survey with quota sampling and
Ye Z, Abduhilil R, Huang J, Sun L.
europepmc   +4 more sources

A framework for extending the health-related quality adjusted life year by combining instruments [PDF]

open access: goldHealth and Quality of Life Outcomes
Current measurement systems focus mostly on health, and not on multiple constructs of quality of life outcomes (for example health and social outcomes) together.
Brendan Mulhern   +6 more
doaj   +3 more sources

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life. [PDF]

open access: yesEur J Health Econ, 2022
Cost-effective threshold (CET) is essential for health technology assessment and decision-making based on health economic evaluations. Recently, it has been argued that the commonly used once and three times of gross domestic product (GDP) per capita ...
Cai D   +5 more
europepmc   +2 more sources

Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. [PDF]

open access: yesPharmacoecon Open, 2020
Background No willingness-to-pay (WTP) per quality-adjusted life-year (QALY) value exists for the Kingdom of Saudi Arabia (KSA). Objective The primary objective of this study was to determine the WTP for a QALY in the KSA.
Bazarbashi S   +7 more
europepmc   +2 more sources

Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018. [PDF]

open access: yesMedicine (Baltimore), 2020
To examine the willingness to pay (WTP) for a quality-adjusted life year (QALY) gained among advanced non-small cell lung cancer (NSCLC) patients in Viet Nam and to analyze the factors affecting an individual's WTP.
Ha TV   +8 more
europepmc   +2 more sources

Multivariate risk preferences in the quality-adjusted life year model. [PDF]

open access: yesHealth Econ, 2022
AbstractThe interest in multivariate and higher‐order risk preferences has increased. A growing body of literature has demonstrated the relevance and impact of these preferences, but for health the evidence is lacking. We measure multivariate and higher‐order risk preferences for quality of life (QoL) and longevity, the two attributes of the Quality ...
Attema AE, Frasch JJ, L'Haridon O.
europepmc   +8 more sources

QALY: Quality Adjusted Life Year

open access: yesMedicine Science, 2012
Nufusun yaslanmasi ve yaslilik donemi hastaliklar ile kronik hastaliklarin one cikmasi verilen saglik hizmetlerinin sadece saglik duzeyi uzerine degil yasam kalitesine etkisinin de onemli bir cikti olarak degerlendirilmesini getirmistir.
Selale Sahin, Selime Toprak, Erdinc Unal
doaj   +2 more sources

Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey. [PDF]

open access: yesMedicine (Baltimore), 2018
Cost-effectiveness is 1 of the most important factors in medicine reimbursement, and social willingness to pay (WTP) can provide evidence for the threshold of cost-effectiveness analysis.
Song HJ, Lee EK.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy